盐酸法舒地尔治疗缺血性脑卒中的临床观察被引量：2

下载PDF

导出

摘要目的观察早期使用Rho激酶抑制剂盐酸法舒地尔治疗缺血性脑卒中的疗效。方法选择缺血性脑卒中患者220例,随机分为治疗组和对照组,每组110例。对照组给予常规治疗,治疗组在此基础上给予盐酸法舒地尔。观察两组患者治疗前后NIHSS评分并评定疗效。结果治疗后,治疗组的神经功能缺损评分为(3.43±4.76),明显低于对照组的(7.12±5.25)(P<0.01);治疗组的总有效率为92.7%,明显高于对照组的77.3%(P<0.01)。结论缺血性脑卒中患者早期(48h内)应用法舒地尔可有效改善神经功能和临床疗效。

作者倪福文袁莉刘乙毅

机构地区广东省茂名市人民医院神经内科

出处《广东医学院学报》 2010年第4期401-402,共2页 Journal of Guangdong Medical College

关键词缺血性脑卒中治疗法舒地尔 RHO激酶抑制剂

分类号 R743.3 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献10

1Shibuya M, Hirai S, Seto M, et al. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial [J].J Ncurol Sci, 2005, 238 (1) : 31-39.
2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量：33091
3脑卒中患者临床神经功能缺损程度评分标准（1995）[J].中华神经科杂志,1996,29(6):381-383. 被引量：15780
4Shin H K,Salomonc S, Pott s E M, et al. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischcmia via endothelial mechanisms [J]. J Cereb Blood Flow Metab, 2007, 27:998-1009.
5Schmidt J T, Morgan P, Dowell N, et al. Myosin light chain phosphorylation and growth cone motility [J]. J Neurobiol, 2002, 52:175- 188.
6Diebold B A, Fowler B, Lu J, et al. Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species [J]. J Biol Chem, 2004, 279:28136-28142.
7Shi J, Wei L. Rho kinase in the regulation of cell death and survival [J].Arch Immunol Ther Exp, 2007, 55:61-75.
8Shah D I, Singh M. Involvement of Rho-kinase in experimental vascular endothelial dysfunction [J]. Mol Cell Biochcm, 2006, 283 (122): 191-199.
9Satoh S, Toshima Y, Ikegaki I, et al. Wide therapeutic time window for fasudil neuroprotection against ischemia induced delayed neuronal death in gerbils [J]. Brain Res, 2007, 1128(1) : 175-180.
10张琳,王超,董太和,直玉秋,朱柒锦,许冬青,王利宇.盐酸法舒地尔治疗急性脑梗死的临床研究[J].实用心脑肺血管病杂志,2006,14(5):362-363. 被引量：22

二级参考文献9

1史玉泉,周孝达,主编.实用神经病学[M].上海:上海科学技术出版社,2005:806-813.
2Seto M,Shindo K,Ito K,et al.Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077[J].Eur J Pharmacol,1995,276(1-2):27-33.
3Asano T,Ikegaki I,Satoh S,et al.Mechanism of action of a novel antivasospasm drug,HA1077[J].J Pharmacol Exp Ther,1987,241(3):1033-1040.
4Hattis RJ,Branston NM,Symon L,et al.The effects of a calcium antagonist,nimodipine,upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischemia[J].Stroke,1982,13:759-766.
5Gotoh O,Mohamed AA,McCulloch J,et al.Nimodipine and the hemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat[J].J Cereb Blood Flow Metab,1986,6:321-331.
6Barnett GH,Bose B,Little JR,et al.Effects of nomodipine on acute focal cerebral ischemia[J].Stroke,1986,17:884-890.
7Mies G,Ishimatu S,Xie Y,et al.Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat[J].J Cerrb Blood Flow Metab,1991,11:753-761.
8佟怀宇,余新光,许百男.盐酸法舒地尔治疗蛛网膜下腔出血后迟发脑血管痉挛[J].军医进修学院学报,2002,23(1):53-56. 被引量：28
9王素香.脑梗死的治疗[J].中国全科医学,2004,7(4):215-216. 被引量：23